Why XORTX (XRTX) Shares Are Gaining Today
[ad_1] XORTX Therapeutics Inc XRTX has announced topline results from the XRX-OXY-101 – Bridging Pharmacokinetics Clinical Trial characterizing the pharmacokinetics of formulated oral oxypurinol, XORLO. The study showed that XORLO was…
Cancer Genomics-Focused Personalis To Reduce Nearly One-Third Of Its Workforce
[ad_1] Personalis Inc PSNL approved a reduction in the company’s workforce by up to approximately 30% to reduce operating costs and improve operating efficiency. The reduction in workforce is expected to…
Horizon Therapeutics Touts Positive Data From Mid-Stage Study For Immune System Disorder
[ad_1] Horizon Therapeutics plc’s HZNP Phase 2 trial evaluating dazodalibep for Sjögren’s syndrome met its primary endpoint in the second patient population. Sjogren’s syndrome is an immune system disorder identified…
Calyxt Shares Surge On Merger Agreement Creating Agriculture-Focused Precision Gene Editing Company
[ad_1] Calyxt Inc CLXT has agreed to merge with Cibus in an all-stock transaction to create a company focused on agriculture-based gene editing and establish facilities for trait development and next-generation plant breeding. …
Bankrupt Crypto Hedge-Fund Firm Plans Trading Platform For Fallen Crypto Debt
[ad_1] The founders of a bankrupt crypto hedge-fund firm, Three Arrows Capital Ltd, are reportedly looking for capital infusion to launch an exchange where creditors to insolvent digital-assets firms, including their…